Youare involveo
selectingacandidatedrugforfurthercinicatdevelopment as anantihypertensive agent.
Youhavebeen provided with dataconcerning anumberofdifferentcompoundsunder investigation
Whichofthefouowinqcompounds.accordinqtoitsmodeof clearance, ismostuikeuy to show stable
pharmacokineticpropertieswhen tested between patients?
CompoundA ispredominanty cleared viathekidneys
CompoundBispredominantly cearedvia theCYP2D6route
ComooundCisone-thirdcearedbythekdnevsandtwvo-thirds bvtwodifferemt P450isoforms.
neitherbv CYP2D6
CompoundDis50%ceared by CYP2D6,50%by anotherP450 isoform
CompoundEispredominanty ceared va CYP3A4
1018
@1MiNDOCRINE
